Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|July 13, 2004
Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathwaysKirk W Siddals, Emma Marshman, Melissa Westwood, et al.
Pediatric Research|March 25, 2011
Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GHMelissa Westwood, Shahin H Tajbakhsh, Kirk W Siddals, et al.
The Journal of Biological Chemistry|April 2, 2011
Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralizationKirk W Siddals, Justine Allen, Smeeta Sinha, et al.
Clinical Endocrinology|June 10, 2005
The effect of atorvastatin on serum lipoproteins in acromegalyManoj Mishra, Paul Durrington, Mike Mackness, et al.
Diabetes Care|October 27, 2004
The impact of abnormalities in IGF and inflammatory systems on the metabolic syndromeKalpana Kaushal, Adrian H Heald, Kirk W Siddals, et al.
European Journal of Endocrinology|January 22, 2013
Atorvastatin administration is associated with dose-related changes in IGF bioavailabilityRam P Narayanan, Matthew Gittins, Kirk W Siddals, et al.
Annals of Clinical Biochemistry|October 2, 2013
Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetesRam P Narayanan, Bo Fu, Robert L Oliver, et al.
Endocrine Connections|June 20, 2013
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetesRam P Narayanan, Bo Fu, Adrian H Heald, et al.
Pageof 1